Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis

Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis

<b>: </b>Background: Recurrent respiratory papillomatosis (RRP) is a rare disorder characterized by the generation of papillomas of the aerodigestive tract, usually associated with human papilloma virus (HPV) subtypes 6, 11. INO-3106 is a DNA plasmid-based immunotherapy targeting E6 and...

Full description

Bibliographic Details
Main Authors: Charu Aggarwal, Roger B. Cohen, Matthew P Morrow, Kimberly A Kraynyak, Albert J Sylvester, Jocelyn Cheung, Kelsie Dickerson, Veronique Schulten, Dawson Knoblock, Elisabeth Gillespie, Joshua M. Bauml, Jian Yan, Malissa Diehl, Jean Boyer, Michael Dallas, J. Joseph Kim, David B Weiner, Jeffrey M. Skolnik
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Vaccines
Subjects:
hpv
immunotherapy
rrp
Online Access:https://www.mdpi.com/2076-393X/8/1/56

Internet

https://www.mdpi.com/2076-393X/8/1/56

Similar Items